Lumos Pharma(LUMO) - 2022 Q4 - Earnings Call Transcript

Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2022 Earnings Conference Call March 1, 2023 4:30 PM ET Company Participants Lisa Miller - Senior Director, IR Richard Hawkins - CEO & Chairman Lori Lawley - CFO & Principal Accounting Officer John McKew - Chief Scientific Officer & President David Karpf - Chief Medical Officer Conference Call Participants Peter Rosenthal - Cantor Catherine Novack - Jones Trading Eun Yang - Jefferies Ed White - H.C. Wainwright & Co. Operator Good afternoon, and welcome to Lumos Pharma's 20 ...